Tissue engineering strategies for bone regeneration

被引:287
作者
Mistry, AS [1 ]
Mikos, AG [1 ]
机构
[1] Rice Univ, Dept Bioengn, Houston, TX 77005 USA
来源
REGENERATIVE MEDICINE II: CLINICAL AND PRECLINICAL APPLICATIONS | 2005年 / 94卷
关键词
bone; mesenchymal stem cell; growth factor; biodegradable scaffold; bioreactor;
D O I
10.1007/b99997
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Bone loss due to trauma or disease is an increasingly serious health problem. Current clinical treatments for critical-sized defects are problematic and often yield poor healing due to the complicated anatomy and physiology of bone tissue, as well as the limitations of medical technology. Bone tissue engineering offers a promising alternative strategy of healing severe bone injuries by utilizing the body's natural biological response to tissue damage in conjunction with engineering principles. Osteogenic cells, growth factors, and biomaterial scaffolds form the foundation of the many bone tissue engineering strategies employed to achieve repair and restoration of damaged tissue. An ideal biomaterial scaffold will provide mechanical support to an injured site and also deliver growth factors and cells into a defect to encourage tissue growth. Additionally, this biomaterial should degrade in a controlled manner without causing a significant inflammatory response. The following chapter highlights multiple strategies and the most recent advances in various areas of research for bone tissue regeneration.
引用
收藏
页码:1 / 22
页数:22
相关论文
共 113 条
  • [1] In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector
    Alden, TD
    Pittman, DD
    Hankins, GR
    Beres, EJ
    Engh, JA
    Das, S
    Hudson, SB
    Kerns, KM
    Kallmes, DF
    Helm, GA
    [J]. HUMAN GENE THERAPY, 1999, 10 (13) : 2245 - 2253
  • [2] *AM AC ORTH SURG, 2003, FACTS FRACT
  • [3] *AM CANC SOC, 2003, KEY STAT BONE CANC
  • [4] Fundamentals of biomechanics in tissue engineering of bone
    Athanasiou, KA
    Zhu, CF
    Lanctot, DR
    Agrawal, CM
    Wang, X
    [J]. TISSUE ENGINEERING, 2000, 6 (04): : 361 - 381
  • [5] Growth factor delivery for tissue engineering
    Babensee, JE
    McIntire, LV
    Mikos, AG
    [J]. PHARMACEUTICAL RESEARCH, 2000, 17 (05) : 497 - 504
  • [6] Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene
    Baltzer, AWA
    Lattermann, C
    Whalen, JD
    Wooley, P
    Weiss, K
    Grimm, M
    Ghivizzani, SC
    Robbins, PD
    Evans, CH
    [J]. GENE THERAPY, 2000, 7 (09) : 734 - 739
  • [7] Design of a flow perfusion bioreactor system for bone tissue-engineering applications
    Bancroft, GN
    Sikavitsas, VI
    Mikos, AG
    [J]. TISSUE ENGINEERING, 2003, 9 (03): : 549 - 554
  • [8] Fluid flow increases mineralized matrix deposition in 3D perfusion culture of marrow stromal osteloblasts in a dose-dependent manner
    Bancroft, GN
    Sikavitsast, VI
    van den Dolder, J
    Sheffield, TL
    Ambrose, CG
    Jansen, JA
    Mikos, AG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (20) : 12600 - 12605
  • [9] Bancroft GN, 2001, INT CONGR SER, V1222, P151
  • [10] In vivo evaluation of gene therapy vectors in ex vivo-derived marrow stromal cells for bone regeneration in a rat critical-size calvarial defect model
    Blum, JS
    Barry, MA
    Mikos, AG
    Jansen, JA
    [J]. HUMAN GENE THERAPY, 2003, 14 (18) : 1689 - 1701